Skip to content

Clinical trials

Genetic Diseases, Inborn trials in France

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Genetic Diseases, Inborn Country / region: France Clear all

90 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20062
20092
20104
20116
20132
20141
20153
20165
20173
20186
20198
20201
202110
202210
20234
20248
20256
20268

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed39
Recruiting20
Terminated10
Unknown status7
Active, not recruiting6
Not yet recruiting4
Enrolling by invitation4

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Assistance Publique - Hôpitaux de Paris7
QED Therapeutics, a BridgeBio company7
GenSight Biologics5
Hospices Civils de Lyon5
ModernaTX, Inc.5
Novo Nordisk A/S5
Novartis Pharmaceuticals4
BioMarin Pharmaceutical3
Institut National de la Santé Et de la Recherche Médicale, France3
Vertex Pharmaceuticals Incorporated3

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Genetic Diseases, Inborn90
Nervous System Diseases18
Musculoskeletal Diseases13
Neurodegenerative Diseases10
Bone Diseases8
Osteochondrodysplasias8
Dwarfism7
Eye Diseases7
Hematologic Diseases7
Mucopolysaccharidosis IV7

Trials

Showing 1 to 25 of 90. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.